MTVA Marshall H Woodworth buys $10K worth of shares
Jun 05, 2025, 4:35 AM
0.00%
What does MTVA do
NeuroBo Pharmaceuticals, based in Cambridge, Massachusetts, develops multi-modal therapies, including DA-1241 for MASH and Type 2 Diabetes, and DA-1726 for obesity. The company went public on August 5, 2016.
Marshall H Woodworth bought 14,200 shares of MTVA on 4 June at $0.70 per share, worth a total of $10K. They now own 44,279 MTVA shares, or a 47% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.